Introduction {#s1}
============

Cardiac resynchronization therapy (CRT) improves symptoms and reduces morbidity and mortality in symptomatic heart failure patients with left bundle branch block and reduced ejection fraction.^[@r1]--[@r8]^ A fully transvenous CRT implant is preferable to using the combined transvenous and epicardial approach but it can be difficult to implement or unsuccessful in up to 10% of patients eligible for CRT,^[@r9]^ which has led to a search for alternatives to traditional resynchronization, such as His-bundle pacing.^[@r10]^ The major challenge inherent with the transvenous technique is the achievement of stable coronary sinus (CS) catheterization necessary to introduce the left ventricular (LV) lead and advance it into the coronary venous system.^[@r11]^ Difficulties usually arise from the anatomy of CS, spatial orientation of its ostium, and anatomical deformations attributable to cardiac dilatation or embryological variation. Obstructions in veins such as valves and kinking are also common.^[@r12]--[@r14]^ In addition to the operator's experience, several techniques, including phlebography, coronary angiography, intracavitary electrogram, and the application of auxiliary catheters, have been described to facilitate CS catheterization.^[@r15]--[@r19]^ Despite being well-established as a treatment modality, the use of CRT remains challenging, mainly because of the nonresponder rate, and the risks of procedural failures reach 13% in most published trials.^[@r15],[@r20]^ The search for alternative tools and techniques continues to reduce the complexity of CRT implantation and decrease the rate of LV lead placement failure. Despite the advances made, however, the technique for implantation is still dependent on radioscopy. In this context, the anatomical knowledge and its relationship with radiology are essential to achieving a higher success rate.

This report emphasizes the importance of phlebography in anteroposterior (AP), left anterior oblique (LAO), and right anterior oblique (RAO) projections in CRT. It also tries to identify difficult cases and search for a landmark to improve CS catheterization and LV lead placement by using simple anatomical and radiological aspects in patients with a classical indication for CRT. Finally, it reviews the concepts related to the applied radiological anatomy of the cardiovascular system, particularly in patients with dilated cardiomyopathy.

Methods {#s2}
=======

Patients {#s2a}
--------

Patients with dilated cardiomyopathy who were candidates for CRT in a single-center experience were enrolled and included in this prospective study. The same operator performed all the procedures. To be a candidate for CRT, patients had to have dilated heart failure despite optimized medical therapy, New York Heart Association (NYHA) functional class III or IV symptoms, left bundle branch block with QRS duration of greater than 150 ms, an LV ejection fraction of less than 40%, and a life expectancy of not shorter than one year. This study was approved by an investigational review board and patient consent was gathered via a consent form.

Implantation procedure {#s2b}
----------------------

Implantations were performed in the catheterization laboratory. Patients were placed under local anesthesia and sedation when necessary. Prophylactic antibiotics were administered intravenously in all patients. The radiological anatomy of the CS was studied in AP, 30° LAO, and 30° RAO projections. Electrodes for electrocardiographic monitoring were attached to the patient's back to avoid interference with the image of the cardiac silhouette.

The left cephalic vein was a preferred route for active fixation of the right atrial and right ventricular (RV) leads. An inserted atrial lead was not fixed before successful LV lead positioning, whereas an RV lead was immediately attached at the RV apex or midseptum, with the lead body left "to rest" at the base of the right atrium **([Figure 1](#fg001){ref-type="fig"})**. In this way, the systolic motion of the RV lead without the guidewire, seen in the 30° RAO projection, identified the tricuspid annular plane (TAP) **([Figure 2](#fg002){ref-type="fig"})**.

For LV lead positioning, passive "over-the-wire" leads were used. Left subclavian or left axillary vein puncture was preferred to afford sufficient area for manipulation of the sheath and catheters for CS approach. After the puncture, a guiding sheath was positioned at the TAP. A guidewire, a preformed lead, or a deflectable catheter (preferred option) was introduced through the sheath to explore and cannulate the CS. CS phlebography was always performed in the three projections. The radiolucent area seen in the 30° RAO projection, corresponding to the atrioventricular groove, was used thereafter as a reference above, where we expected to find the CS on the left side and the TAP on the right side **([Figure 1](#fg001){ref-type="fig"})**.^[@r21]^ **[Figure 3](#fg003){ref-type="fig"}** shows the implanted leads in all three projections and clockwise and counterclockwise movements at the top and bottom of the radiolucent area facilitated CS catheterization. The position of the LV lead at the CS was confirmed in the 30° LAO view; in this context, the lead should point to and cross the line reference of the spinal column from right to left. Collected images were compared with previous CS phlebography records.

After cannulating the CS, the LV lead was advanced, preferably into the left marginal, the left posterior, or a middle cardiac vein, avoiding the great cardiac vein. The atrial lead was fixed before removing the LV guiding sheath to avoid displacement of the LV lead. The ideal LV site should demonstrate a low and stable LV pacing threshold (≤ 1.5 V at 0.40 ms) and no extracardiac stimulation at the high output (≥ 4.5 V at 0.50 ms). This triad, associated with the removal of the lead delivery system without lead displacement, guaranteed the success of the procedure. **[Figure 3](#fg003){ref-type="fig"}** shows the implanted leads in all three projections.

Definition of variables {#s2c}
-----------------------

We analyzed the success rates and time intervals. CS catheterization was regarded as stable if there was secure positioning of the sheath and subsequent placement of the LV lead or the balloon catheter to perform phlebography. We defined "time from puncture to stable catheterization" as the time interval from central venous access to stable catheterization of the CS. Catheterization failure was defined as an inability to achieve stable catheterization within 120 minutes after puncture.

Likewise, "time from stable catheterization to final LV lead position" was defined as the time interval from stable CS catheterization to successful final LV lead positioning, with all tests done and the sheath removed. The sum of this time and the time from puncture to stable catheterization was defined as the "time from puncture to final LV lead position." The reasons for failed LV lead positioning after successful CS catheterization included the inability to achieve stable LV lead position due to an anatomical barrier, high LV pacing threshold, and/or nonpreventable phrenic nerve stimulation. After each procedure, a questionnaire was applied to evaluate the perception of the level of difficulty related to CS catheterization and LV lead positioning.

Statistical analysis {#s2d}
--------------------

Data were tabulated in Excel 2011 for Mac® (Microsoft Corp., Redmond, WA, USA) and analyzed with the Statistical Package for the Social Sciences version 20.0 for Windows® (IBM Corp., Armonk, NY, USA). Continuous variables are reported as means ± standard deviations (minimum--maximum) and medians (interquartile ranges). Categorical data are reported as absolute and relative frequencies. All data were compared by sex. The time intervals defined in the previous section were additionally compared by LV ejection fraction (with the mean LV ejection fraction acting as the cutoff value), NYHA class, and spatial orientation of the CS ostium. Continuous data were non-normally distributed (assessed by the Kolmogorov--Smirnov--Lilliefors test) and were, hence, compared with the Mann--Whitney U test. Categorical data were compared using the exact Pearson's chi-squared test. A two-sided p-value of less than 0.05 was considered to be statistically significant.

Results {#s3}
=======

We performed 117 phlebographies in 38 consecutive patients (one reintervention) referred for CRT. Male sex slightly prevailed (55%) and male patients showed significantly worse ejection fraction (28% ± 6% versus 34% ± 3%; p = 0.008) and NYHA class (3.6 ± 0.4 versus 3.2 ± 0.3; p = 0.008) profiles than female patients despite nonsignificant younger ages in the former. The major causes of dilated cardiomyopathy were ischemia and valvular disease in males and hypertension and Chagas disease in females **([Table 1](#tb001){ref-type="table"})**. About three-quarters of patients received CRT pacing systems (73.7%) and one-quarter received CRT defibrillation systems (26.3%) for secondary prevention.

All patients underwent one implantation procedure, except for one individual who experienced late LV lead dislodgment and required reintervention. Thus, the total number of procedures was 39, with 117 phlebographies. Serious complications included one case of CS perforation without hemodynamic consequences (diagnosed after phlebography) and one case of pneumothorax requiring surgical drainage. There were no deaths. As such, our complication rate of 5% fell within the range reported in the literature, where overall perioperative complication rates vary from 4% in more recent trials to as high as 28% in earlier CRT trials.^[@r9]^

The attempt made to access the CS was successful 37 times (success rate: 94.9%). One catheterization failure was caused by anomalous CS drainage into the left atrium as was confirmed by coronary angiography during the venous phase. The other catheterization failure occurred in the patient who required two procedures. In this patient, the LV lead was successfully positioned during the initial implantation but, when the LV lead dislodgment necessitated reintervention four months later, it was no longer possible to advance the LV lead into the cardiac veins. The initial implantation was classified as successful but the reintervention was deemed unsuccessful.

Final LV lead positioning succeeded in 36 (92.3%) of 39 procedures. The reasons for failures were catheterization problems, as mentioned above (n = 2), and unfavorable anatomy rendering phrenic nerve stimulation nonpreventable (n = 1). There were no significant differences between males and females concerning the success of stable CS catheterization or final LV lead position **([Table 1](#tb001){ref-type="table"})**. Patients with unsuccessful transvenous implantations were referred for epicardial LV lead placement.

The mean time from puncture to stable CS catheterization was 17 minutes ± 22 minutes, ranging widely from two minutes to 98 minutes. The subsequent time from stable CS catheterization to the final LV lead position was 30 minutes ± 22 minutes (range: 10--107 minutes). The total time was 46 minutes ± 29 minutes (range: 13--121 minutes). Although there were large interpatient differences during all three time intervals, subdivisions according to sex **([Table 1](#tb001){ref-type="table"})** and LV ejection fraction **([Table 2](#tb002){ref-type="table"})** did not result in significant differences between the groups. The same was true after subdivision according to NYHA class **([Table 3](#tb003){ref-type="table"})**. The more severe heart failure and worse LV ejection fraction observed in male patients, thus, did not translate into greater difficulty faced during LV lead implantation.

Regarding the spatial orientation of the CS ostium, 14 (38%) patients showed drainage to the TAP. This prevailed in males (13/21 patients; 62%), while, among females, the CS ostium emptied toward the TAP in only one (6%) of 16 patients.

Discussion {#s4}
==========

Anatomical and radiological considerations of left ventricular lead positioning {#s4a}
-------------------------------------------------------------------------------

The mediastinum is the central compartment of the thoracic cavity, consisting of hollow visceral structures filled with liquid or air and connected by soft connective tissue infiltrated by fat.^[@r22]^ The interpretation of radiological mediastinal shadows and details of cardiovascular anatomy facilitates the correct identification of the CS structures during transvenous LV lead implantation.

The CS is responsible for the venous drainage of the heart. It lies in and is the main constituent of the posterior portion of the atrioventricular groove. CS receives the venous drainage of the anterior half of the interventricular septum and the LV anterior wall through the great cardiac vein, which opens into the left extremity of the CS. The left atrium drains blood into CS via small atrial veins and the oblique vein of left atrium (the vein of Marshall). The lateral wall and a part of the LV posterior region drain blood via the left marginal vein.^[@r13],[@r22],[@r23]^ The rest of the LV posterior region and the posterior half of the interventricular septum drain blood mainly through the left posterior or the middle cardiac vein. At its final portion, the CS receives right venous drainage through the small cardiac vein.

In normal hearts, the atrioventricular groove with CS and the ventricular septal plane typically form a "T" shape as shown in **[Figure 4](#fg004){ref-type="fig"}**. In some cases, a "Y" shape can be seen **([Figure 5](#fg005){ref-type="fig"})** because the CS is situated superior to the atrioventricular groove and is turned posterosuperior to the left atrium. Whether the "Y" shape may be a consequence of an enlarged left or right ventricle or is the result of embryonic development is unknown. With the "Y" shape, the CS ostium, commonly situated in the lower part of the right atrial septum, may change its spatial orientation, with important implications for procedures requiring CS catheterization such as CRT or electrophysiological study. In conventional orientation, CS directs the blood flow toward the venous sinus but, in cases of geometry distortion, it may direct the blood to the inlet of the right ventricle and the TAP as seen in **[Figure 6](#fg006){ref-type="fig"}**. The apex of the heart points approximately 45° to the sagittal and coronal planes (ie, 45° to the left and forward). An enlarged LV chamber tends to tilt the axis of the heart more medial and posteriorly and can thus change the orientation of the axis of the CS. The concomitant enlargement of the right ventricle tends to divert the left ventricle further back, which can additionally shift the axis of the CS. In the LAO projection, the septum adopts a more axial point, with the right cavities located rightmost and left cavities located leftmost of the observer **([Figure 3](#fg003){ref-type="fig"})**. In this way, the CS adopts a posterior upward trend related to the back of the patient, whereas the CS ostium is moved toward the observer. In the RAO view, the heart is projected from the side or transversally; therefore, the right chambers are available in the front, overlapping the left chambers. The CS ostium is again drawn nearer to the observer. Precisely in this projection, the geometric deformation imposed by dilated cardiomyopathy diverts the direction of the axis of the CS to the back (ie, toward the column and to the observer's right). It is not uncommon that, in these conditions, the blood flows from the CS toward the TAP **([Figure 6](#fg006){ref-type="fig"})**.

In the population studied, there was a difference between the sexes in the spatial orientation of the CS ostium, with the direction to the TAP being more common in males and very uncommon in females. It is not possible to affirm that the differences observed here are solely related to anatomical variations between the sexes or the etiology of cardiomyopathies, since this was not a designed endpoint. We also observed that cases of CS ostium with TAP orientation initially presented as more difficult cases considering catheterization; this aspect was neutralized at the end of the study. Indeed, the time for LV lead positioning and the subjective perception of difficulty were higher for cases in which the CS ostium pointed to the TAP **([Table 4](#tb004){ref-type="table"} and [Figure 7](#fg007){ref-type="fig"})**.

Accessing coronary sinus ostium {#s4b}
-------------------------------

The main limiting factor for accessing the CS ostium is operator experience.^[@r24]^ Among several techniques, three are frequently used in medical practice. The first and the one most commonly used by electrophysiologists relies on the AP or 30° LAO view to "fish" the CS with a catheter or a preshaped lead. It is possible to form lead guides for this purpose or to use a special catheter. Some surgeons continuously record the intracavitary electrogram associated with radiological imaging to determine the CS position. The electrogram can be obtained from the LV lead (which can decrease procedure time) or with the aid of an electrophysiology catheter.^[@r25]^ The third methodology (phlebography) is standard for interventional cardiologists and consists of making small injections of contrast near the atrioventricular groove to visualize the CS ostium. This is generally done in AP or 30° LAO projections.

Commonly, CS can be accessed by trial and error. Not infrequently, the CS is even accessed unintentionally during conventional RV lead implantation. Currently, successful CS catheterization and LV lead placement seem to be more related to the anatomical aspects of the dilated heart than the type of resource used. Furthermore, the LV lead profile and its intimate relationship with the cardiac venous system can be decisive for procedure success.^[@r24],[@r26]^

After reviewing a series of phlebographies in our cohort, we observed that difficult access to the CS was mainly attributable to the altered spatial orientation of the CS ostium (ie, if the CS ostium points to the inlet of the right ventricle) **([Figure 6](#fg006){ref-type="fig"})**. We moved to explore a radiolucent area in the 30° RAO projection located toward the column and upward following our indicative phlebography findings. A 30° RAO projection becomes a good key point for LV lead positioning in such a context.

Gonzalez-Vasserot et al. analyzed the CS drainage in a study of the venous phase of angiography in 35 patients.^[@r27]^ They used a 30° RAO view and the radiolucent area as described by Josephson.^[@r21]^ The authors suggested that the anatomical location of the CS in this projection may be used to facilitate interventional procedures that require access to the CS. However, the study included only four patients with dilated cardiomyopathy and the findings could not be extrapolated to patients with dilated hearts. In another study, Da Costa et al. used 64-slice computed tomography to analyze the cardiac anatomy of patients with difficult CRT implantation; the only anatomical factor predicting implantation difficulty was a greater distance of the CS ostium from the floor of the right atrium.^[@r28]^ Macias et al. reported LV lead implantation failure in 26 (12.3%) of 212 patients.^[@r29]^ During logistic regression analysis, the presence of permanent atrial fibrillation and a larger left atrium diameter in the AP view were independent predictors of a failed implant.

In our study, the CS ostium oriented toward the inlet of the right ventricle was associated with LV lead implantation difficulty. The 30° RAO projection, on top of the AP and 30° LAO projections, allowed for better assessment of the geometric distortion of the CS to facilitate its catheterization in a group of patients with dilated cardiomyopathy.

Conclusion {#s5}
==========

This study is an exploratory study of a single-center experience and does not pretend to extrapolate its limitations. The existence of numerous techniques shows that there is no gold standard for transvenous LV lead placement in patients undergoing CRT implantation. Despite all the evolution that has occurred in CRT, the procedure remains dependent on fluoroscopy and the anatomical and radiological knowledge acquired in clinical practice. The methodology we discuss is based on the simple application of knowledge of radiological and anatomical aspects of the CS in dilated cardiomyopathy. AP, LAO, and RAO projections should always be standard on CRT. The RAO projection was, in this study, useful in the access of difficult CS ostia for LV lead positioning, especially when the CS ostium pointed to the TAP, particularly in males. During CRT procedures, the RAO projection may serve as a means to complete more time-consuming technically complex cases.

![RAO projection at 30°, showing an inserted right atrial lead, a fixed RV lead, a deflectable catheter placed in the CS, and a schematic presentation of the anatomical--radiological cardiac silhouette. A: atrium; RA: radiolucent area; CS: coronary sinus; T: tricuspid annular plane; V: ventricle.](icrm-11-4161-g001){#fg001}

![RAO projection at 30° during CS phlebography in the diastole (left) and at the end of systole (right). Arrows indicate RV lead motion at the site of the TAP.](icrm-11-4161-g002){#fg002}

![Spatial orientation of the cardiac chambers in the 30° LAO, AP, and 30° RAO projections. Observe the layout of the biventricular system. L: left; R: right.](icrm-11-4161-g003){#fg003}

![Diaphragmatic view of the normal heart. Observe the "T" shape formed by the CS (horizontal line) and the interventricular sulcus (vertical line). (This photograph was originally presented in the first author's doctoral dissertation.)](icrm-11-4161-g004){#fg004}

![Diaphragmatic view of an enlarged heart. Observe the "Y" shape formed by the CS and the interventricular sulcus. (The photograph was originally presented in the first author's doctoral dissertation.)](icrm-11-4161-g005){#fg005}

![Two different CS phlebographies in the 30° RAO projection showing blood flow drainage. **A:** Blood flow points to the venous sinus. **B:** Blood flow points to the inlet of the right ventricle. T: tricuspid annular plane.](icrm-11-4161-g006){#fg006}

![LV lead positioning view on radioscopy in two different patients (30° RAO and 30° LAO projections). The top is considered a difficult case and the bottom is considered an easy case with respect to CS catheterization and lead delivery.](icrm-11-4161-g007){#fg007}

###### 

Patient Characteristics at Baseline, Procedure Success, and Time Intervals

  Characteristic                                               Total (n = 38)      Male (n = 21)       Female (n = 17)    p-value
  ------------------------------------------------------------ ------------------- ------------------- ------------------ ---------
  Age, years                                                   0.243\*                                                    
   Mean ± SD (min--max)                                        61 ± 10 (42--81)    59 ± 11 (42--81)    63 ± 9 (47--78)    
   Median (IQR)                                                61.5 (52--68)       60 (50--69)         63 (57--68)        
  LVEF, %                                                      0.008\*                                                    
   Mean ± SD (min--max)                                        31 ± 6 (17--38)     28 ± 6 (17--38)     34 ± 3 (25--38)    
   Median (IQR)                                                32 (28--34)         30 (22--34)         34 (32--36)        
  NYHA class, mean ± SD                                        3.4 ± 0.4           3.6 ± 0.4           3.2 ± 0.3          0.008\*
   Class III, n (%)                                            27 (71.1)           11 (52.4)           16 (94.1)          
   Class IV, n (%)                                             11 (28.9)           10 (47.6)           1 (5.9)            
  Etiology, n (%)                                                                                                         
   Idiopathic                                                  6 (15.8)            5 (23.8)            1 (5.9)            
   Ischemic                                                    11 (28.9)           7 (33.3)            4 (23.5)           
   Chagasic                                                    5 (13.2)            0                   5 (29.4)           
   Ischemic and chagasic                                       1 (2.6)             1 (4.8)             0                  
   Valvular                                                    4 (10.5)            4 (19, 0)           0                  
   Hypertensive                                                9 (23.7)            3 (14.3)            6 (35.3)           
   Myocarditis                                                 1 (2.6)             1 (4.8)             0                  
   ARVD                                                        1 (2.6)             0                   1 (5.9)            
  Implanted device, n (%)                                                                                                 
   CRT                                                         25 (65.8)           12 (57.1)           13 (76.5)          
   CRT without atrial lead                                     3 (7.9)             3 (14.3)            0                  
   CRT-D                                                       8 (21.1)            5 (23.8)            3 (17.6)           
   CRT-D without atrial lead                                   2 (5.3)             1 (4.8)             1 (5.9)            
  Procedure success rates, n (%)^†^                                                                                       
   Stable CS catheterization                                   37 (94.9)           21 (100.0)          16 (88.9)          0.387\*
   Final LV lead position                                      36 (92.3)           21 (100.0)          15 (83.3)          0.526\*
  Time interval, min, mean ± SD (min--max)                                                                                
   From puncture to stable CS catheterization                  17 ± 22 (2--98)     20 ± 28 (2--98)     14 ± 9 (4--30)     0.387\*
    For 37 successful catheterizations, median (IQR)           8 (5--23)           6 (4--26)           12 (6--21)         
   From stable CS catheterization to final LV                  30 ± 22 (10--107)   32 ± 26 (10--107)   26 ± 14 (10--62)   0.950\*
    Lead position (for 36 successful implants), median (IQR)   25 (17--31)         21 (19--5)          25 (14--31)        
   From puncture to final LV lead position                     47 ± 29 (13--121)   52 ± 35 (13--121)   40 ± 18 (16--76)   0.526\*
    For 36 successful implants, median (IQR)                   40 (25--55)         37 (26--69)         42 (24--53)        

ARVD: arrhythmogenic right ventricular dysplasia; CS: coronary sinus; CRT-D: CRT with defibrillator backup; IQR: interquartile range; LV: left ventricular; LVEF: left ventricular ejection fraction; NYHA: New York Heart Association; SD: standard deviation.

\*Mann--Whitney U test.

^†^A total of 39 implantation procedures were included in the analyses, as one woman underwent two procedures.

###### 

Time Intervals as Function of LVEF (Median)

  Time Interval, min                             LVEF ≤ 31% (n = 14)   LVEF \> 31% (n = 23)   p-value
  ---------------------------------------------- --------------------- ---------------------- -------------
  From puncture to stable CS catheterization\*                                                0.284\*\*\*
   Mean ± SD (min--max)                          21 ± 24 (2--98)       14 ± 20 (3--97)        
   Median (IQR)                                  19 (6--27)            7 (4--17)              
  From puncture to final LV lead position\*\*                                                 0.860\*\*\*
   Mean ± SD (min--max)                          48 ± 31 (13--121)     46 ± 28 (17--115)      
   Median (IQR)                                  44 (28--57)           36 (25--57)            

CS: coronary sinus; IQR: interquartile range; LV: left ventricular; LVEF: left ventricular ejection fraction; SD: standard deviation.

\*Excluding one patient with anomalous drainage of the CS into the left atrium and the redo procedure (total = 37 patients).

\*\*Excluding one patient with anomalous drainage of the CS into the left atrium and the redo procedure and one patient with unpreventable phrenic nerve stimulation (total = 36 patients).

\*\*\*Mann--Whitney U test.

###### 

Time Intervals as Function of NYHA Class

  Time Interval, min                             NYHA III (n = 26)   NYHA IV (n = 11)    p-value
  ---------------------------------------------- ------------------- ------------------- -------------
  From puncture to stable CS catheterization\*                                           0.612\*\*\*
   Mean ± SD (min--max)                          16 ± 19 (3--98)     19 ± 27 (2--97)     
   Median (IQR)                                  9 (6--23)           6 (4--23)           
  From puncture to final LV lead position\*\*                                            0.416\*\*\*
   Mean ± SD (min--max)                          43 ± 24 (16--121)   57 ± 38 (13--115)   
   Median (IQR)                                  36 (25--53)         45 (30--107)        

Abbreviations: CS: coronary sinus; IQR: interquartile range; LV: left ventricular; NYHA: New York Heart Association; SD: standard deviation.

\*Excluding one patient with anomalous drainage of the CS into the left atrium and the redo procedure (total = 37 patients).

\*\*Excluding one patient with anomalous drainage of the CS into the left atrium and the redo procedure and one patient with unpreventable phrenic nerve stimulation (total = 36 patients).

\*\*\*Mann--Whitney U test.

###### 

Time Intervals as Function of CS Ostium to the TAP

  ---------------------------------------------------------------------------------------------------
  Time interval, min                             No CS to the TAP\   Yes CS to the TAP\   p-value
                                                 (n = 22)            (n = 14)             
  ---------------------------------------------- ------------------- -------------------- -----------
  From puncture to stable CS catheterization\*                                            

   Mean ± SD (min--max)                          11 ± 9 (3--33)      27 ± 32 (2--98)      0.180\*\*

   Median (IQR)                                  8 (4--15)           21 (5--28)           

  From puncture to final LV lead position\*                                               

   Mean ± SD (min--max)                          35 ± 17 (13--76)    66 ± 34 (25--121)    0.002\*\*

   Median (IQR)                                  30 (22--49)         53 (37--108)         
  ---------------------------------------------------------------------------------------------------

CS: coronary sinus; IQR: interquartile range; SD: standard deviation; TAP: tricuspid annular plane.

\*Excluding one patient with anomalous drainage of the CS into the left atrium and the redo procedure and one patient with unpreventable phrenic nerve stimulation (total = 36 patients).

\*\*Mann--Whitney U test.
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